Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system

Authors

Noor Naffakh
Michael Williams, Advocate Aurora HealthFollow
Priyam Patel, Advocate Aurora HealthFollow
Rachel Pedersen, Advocate Aurora HealthFollow
Michael Peterson, Advocate Aurora HealthFollow
Anthony DeFranco, Advocate Aurora HealthFollow
Stephen MedlinFollow
Sherjeel Sana, Advocate Aurora HealthFollow
Zartash Gul, Advocate Aurora HealthFollow

Recommended Citation

Williams M, Patel P, Pedersen R, et al. Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system. Journal of Clinical Oncology. 2023;41(16_suppl):e19074-e19074. doi:10.1200/JCO.2023.41.16_suppl.e19074

Type

Abstract